“Biodesign” has become a global phenomenon, with training programs like ours now operating around the world. Over the past decade, Stanford Biodesign has had a hand in inspiring or advising more than 30 educational programs in 18 countries ranging from Israel and India to Singapore and Sweden.
One reason our approach is going global is that our unique biodesign innovation process works everywhere. When you’re identifying needs, whether you’re in a hospital in Palo Alto or an infusion clinic in rural China, it requires you to immerse yourself in the clinical and cultural environment and consider the unique perspectives and priorities of those stakeholders. When you’re inventing a solution, the process forces you to carefully consider exactly how and where it will be used. And when you’re implementing a solution, it again requires you to examine everything from traditions to economics to infrastructure so you can successfully get your product to patients. By innovating in this way, the biodesign innovation process can be used to effectively develop and deliver everything from high-end solutions for affluent populations in well-established markets to low-cost technologies intended to improve access for millions of patients in developing countries.
There are a number of different ways Stanford Biodesign supports global health technology innovation education:
Active Program Development Partners
Stanford Biodesign works with a limited number of program development partners to help them create and launch their own innovation training programs. The development agreement is for a set initial time period and can be renewed/extended as needed until the program can sustain independent status.
- Japan Biodesign: Tokyo University, Tohuko University, Osaka University
Global affiliates are independent programs founded by Stanford Biodesign trainees that maintain a formal association with Stanford Biodesign. We collaborate actively with our affiliates throughout each academic year to share ideas and best practices. In some cases, our trainees interact as well. Affiliate status is reserved for the highest quality Biodesign programs. To be awarded the designation, programs must fulfill specific performance requirements that demonstrate their success and sustainability. They also must undergo a formal review by Stanford Biodesign. As of 2021, only those programs that have previously been Stanford Biodesign joint programs or program development partners are eligible for consideration.
Active Program Development Partners Graduated Partners Global Affiliates Other Programs
- Stanford Byers Center for Biodesign
Palo Alto, California, USA Stanford Biodesign is headquarters for our contacts across the globe. Many of our direct collaborators spend time training with us at Stanford through initiatives such as the Singapore-Stanford Biodesign Fellowship or our Global Faculty Training program.
- Singapore Biodesign
Singapore Modeled after Stanford Biodesign, Singapore Biodesign is a capability development initiative that aims to train and nurture the next generation of health tech innovators for Asia. This program began as Singapore-Stanford Biodesign, a partnership between Stanford University, the Singapore Economic Development Board, and the Agency for Science, Technology, and Research (A*STAR) in 2010. It offered a joint fellowship program with Stanford Biodesign from 2011 until its transition to independent status in late 2018.
- Japan Biodesign
Osaka/Tokyo/Sendai, Japan Japan Biodesign, a Stanford Biodesign Program Development Partner, was established in 2015 in partnership with Osaka, Tokyo and Tohoku Universities and the Japan Federation of Medical Devices, and a fellowship program was launched that same year. Through this partnership, Japan Biodesign faculty are trained at the Byers Center through our Global Faculty Training program and receive ongoing support and mentoring from our core faculty. Japan Biodesign fellows visit Stanford Biodesign for an intensive two-week training experience mid-way through their fellowship year.
- BioInnovate Ireland
Galway, Ireland BioInnovate Ireland opened in 2011 after its program director, Mark Bruzzi, trained with us at Stanford Biodesign. As a Stanford Biodesign affiliate, BioInnovate is an independent program that offers both a fellowship and industry training. Fellows from Stanford Biodesign and BioInnovate collaborate throughout each academic year to share ideas, information, and experiences.
- School of International Biodesign
New Delhi, India The School of International Biodesign is focused on training medical technology innovators and creating an ecosystem of frugal medical innovations in India. This program began as Stanford-India Biodesign, a collaboration between Stanford University, the Indian Institute of Technology Delhi, and the All India Institute of Medical Sciences (AIIMS) in partnership with the Indo-US Science & Technology Forum. From 2008 and 2015, we jointly operated a fellowship program for Indian citizens who spent the first six months of their training at Stanford Biodesign, followed by six to 18 months at AIIMS. Now independent, the School of International Biodesign offers the iFellowship for aspiring medtech entrepreneurs.
- Perth Biodesign
PerthPerth Biodesign launched in 2018 after co-founder Matt Oldakowski completed our global faculty training program. Using the Stanford Biodesign methodology, the program brings together multidisciplinary teams of learners passionate about making a difference in healthcare. Perth Biodesign’s biomedical entrepreneurship programs are experiential in nature, designed for the Australian biomedical environment, and thrive on the support of the local ecosystem.
- Biodesign Rambam
IsraelBiodesign Rambam’s leadership team all trained in Stanford Biodesign programs and courses, including founder Yona Vaisbuch, chief instructor Tahel Altman, and instructors Lior Lev Tov and Nitai Klein. The program is an educational-driven center that is helping build the local health technology ecosystem using the Stanford Biodesign approach to training aspiring innovators. Its goal is to significantly improve patient treatment and well-being around the world.
- TMU Biodesign
TaiwanTMU Biodesign is a health technology training ecosystem anchored by Taipei Medical University. It includes the TMU BioMEd Accelerator, Taiwan's first international medical university-based accelerator, which is led by Stanford Biodesign global faculty trainee Jowy Tani. The accelerator also has a start-up mentorship program supported by other alumni of our programs. Additional ecosystem partners include Wan Fang Biodesign, Shuang-Ho Biodesign, and TMUH Biodesign and Biodesign Jr.
Global Program Leaders
- Robson Capasso Advisor, Global Biodesign
- Lyn Denend Director, Academic Programs
- Rajiv Doshi Director, India Program
- Fumi Ikeno Program Director (US), Japan Biodesign
- Ritu Kamal Associate Director, Global Programs
- Uday Kumar Director, Strategy
- Anurag Mairal Director, Global Outreach Programs
- Jan Pietzsch Director, Health Economics and Value
- Douglas Rait Director, Team Learning and Design
- Sandra Waugh Ruggles Assistant Director, Innovation Fellowship
- Gordon Saul Executive Director
- Chris Shen Executive Director, Singapore-Stanford Biodesign
- Alexei Wagner Global Faculty Clinical Lead
- Shiqin Xu Senior Manager, Course and Global Programs